Results 31 to 40 of about 36,088 (299)

New Approaches for Cryptococcosis Treatment

open access: yesMicroorganisms, 2020
Cryptococcosis is an important opportunistic infection and a leading cause of meningitis in patients with HIV infection. The antifungal pharmacological treatment is limited to amphotericin B, fluconazole and 5- flucytosine.
C. Spadari   +3 more
semanticscholar   +1 more source

Cryptococcosis with bird's eye manifestation: A case report

open access: yesLung India, 2018
Cryptococcosis is a menacing opportunistic infection most commonly affecting immunocompromised individuals. Its occurrence in immunocompetant individuals is uncustomary.
H S Suhas   +4 more
doaj   +1 more source

The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis

open access: yesMsphere, 2017
Cryptococcosis is a potentially lethal disease of humans/animals caused by Cryptococcus neoformans and Cryptococcus gattii. Distinction between the two species is based on phenotypic and genotypic characteristics.
K. Kwon-Chung   +32 more
semanticscholar   +1 more source

Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children [PDF]

open access: yes, 2017
AW and JK are supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of AberdeenPeer reviewedPublisher ...
King, Jill   +4 more
core   +1 more source

Crazy‐paving patterns as rare radiological manifestations of pulmonary cryptococcosis: a case report

open access: yesBMC Pulmonary Medicine, 2021
Background Crazy-paving patterns are rarely reported as radiological manifestations of pulmonary cryptococcosis. Case presentation Herein, we presented a very rare case of a crazy-paving pattern as a radiological manifestation of pulmonary cryptococcosis
He Yu   +8 more
doaj   +1 more source

Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis

open access: yesInternational Journal of Nanomedicine, 2019
Introduction and objective Previous studies indicate that miltefosine (MFS) may be an alternative as an antifungal agent; however, it presents several adverse effects.
C. Spadari   +3 more
semanticscholar   +1 more source

Prevalence of cryptococcosis in Atlántico, department of Colombia assessed with an active epidemiological search

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2019
INTRODUCTION Cryptococcosis is the second most frequent cause of opportunistic infections in human immunodeficiency virus (HIV) patients in Colombia.
María Clara Noguera   +5 more
doaj   +1 more source

Vaccines and Protective Immune Memory against Cryptococcosis.

open access: yesBiological and Pharmaceutical Bulletin, 2020
Cryptococcosis is a potentially lethal disease caused by fungal pathogens including Cryptococcus neoformans and Cryptococcus gattii species complex. These fungal pathogens live in the environment and are associated with certain tree species and bird ...
Keigo Ueno   +3 more
semanticscholar   +1 more source

Application and evaluation of nucleic acid sequence-based amplification, PCR and cryptococcal antigen test for diagnosis of cryptococcosis

open access: yesBMC Infectious Diseases, 2021
Background Cryptococcosis is a major opportunistic invasive mycosis in immunocompromised patients, but it is also increasingly seen in immunocompetent patients.
Yanping Wang   +5 more
doaj   +1 more source

Pulmonary Cryptococcosis: comparison of Cryptococcal antigen detection and radiography in Immunocompetent and Immunocompromised patients

open access: yesBMC Infectious Diseases, 2020
Background We compared the cryptococcal antigen detection and imaging findings between immunocompetent and immunocompromised patients in whom pulmonary cryptococcosis had been diagnosed.
jingqi Min   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy